These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 12855645)
1. Epigenetic inactivation of laminin-5-encoding genes in lung cancers. Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645 [TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
3. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Sathyanarayana UG; Padar A; Suzuki M; Maruyama R; Shigematsu H; Hsieh JT; Frenkel EP; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6395-400. PubMed ID: 14695140 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917 [TBL] [Abstract][Full Text] [Related]
7. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090 [TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194 [TBL] [Abstract][Full Text] [Related]
9. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088 [TBL] [Abstract][Full Text] [Related]
10. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Toyooka S; Fukuyama Y; Wistuba II; Tockman MS; Minna JD; Gazdar AF Clin Cancer Res; 2002 Jul; 8(7):2292-7. PubMed ID: 12114433 [TBL] [Abstract][Full Text] [Related]
14. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521 [TBL] [Abstract][Full Text] [Related]
16. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
17. Differential inactivation of caspase-8 in lung cancers. Shivapurkar N; Toyooka S; Eby MT; Huang CX; Sathyanarayana UG; Cunningham HT; Reddy JL; Brambilla E; Takahashi T; Minna JD; Chaudhary PM; Gazdar AF Cancer Biol Ther; 2002; 1(1):65-9. PubMed ID: 12170765 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]